A new study from Journal of Clinical Endocrinology and Metabolism has found that in polycystic ovary syndrome, vitamin D may have a protective effect against the actions of inflammatory compounds called advanced glycation end products.
Polycystic ovary syndrome (PCOS) is a disorder that is characterized by high levels of androgens (hormones that control male characteristics) and irregular or rare ovulation.
Normally, ovulation occurs when a follicle containing the egg grows and then releases the egg once it reaches maturity. In women with PCOS, the follicle does not release the eggs which begin to accumulate in the ovaries, resulting in the formation of small, benign cysts. PCOS affects 5% to 10% of women of reproductive age.